US 8173362
Cytomegalovirus surface protein complex for use in vaccines and as a drug target
granted A61KA61K2039/505A61K39/12
Quick answer
US patent 8173362 (Cytomegalovirus surface protein complex for use in vaccines and as a drug target) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE TRUSTEES OF PRINCETON UNIVERSITY
- Grant date
- Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K39/12, A61K39/245, A61P